Skip to main content

Ecstasy (MDMA) and its relationship with self report depression, anxiety and schizotypy.

Journal Article


Download full-text (Open Access)

Abstract


  • Abstract. Aims: The relationship between ecstasy and affective psychological symptoms

    are still subject to debate. We aimed to examine the relationship between Ecstasy use and

    self-report depression, anxiety and schizotypy. Design: Data were collected via structured

    remote self-report questionnaires. Participants: Participants were split into three groups: a

    control group with no ecstasy use, a light ecstasy user group (<50 times), and a heavy ecstasy

    user group (>50 times). Measurements: Amount and patterns of ecstasy use were recorded,

    the Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) measured

    depression and anxiety respectively, and schizotypal traits were measured using the schizotypal

    Personality Questionnaire (SPQ). Findings: It was found that ecstasy use was associated

    with depression, anxiety and schizotypal trait scores. There was no relationship between

    these measures and the level of ecstasy use. Conclusions: Ecstasy use per se was associated

    with self-report depression and anxiety, replicating previous literature. Furthermore,

    ecstasy users reported more schizotypal traits, something which had not been investigated

    in any previous research.

    Key words: ecstasy, MDMA,

Publication Date


  • 2010

Citation


  • Woods, L. & Barkus, E. (2010). Ecstasy (MDMA) and its relationship with self report depression, anxiety and schizotypy.. Clinica y Salud, 21 (2), 151-157.

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=1966&context=hbspapers

Ro Metadata Url


  • http://ro.uow.edu.au/hbspapers/917

Number Of Pages


  • 6

Start Page


  • 151

End Page


  • 157

Volume


  • 21

Issue


  • 2

Abstract


  • Abstract. Aims: The relationship between ecstasy and affective psychological symptoms

    are still subject to debate. We aimed to examine the relationship between Ecstasy use and

    self-report depression, anxiety and schizotypy. Design: Data were collected via structured

    remote self-report questionnaires. Participants: Participants were split into three groups: a

    control group with no ecstasy use, a light ecstasy user group (<50 times), and a heavy ecstasy

    user group (>50 times). Measurements: Amount and patterns of ecstasy use were recorded,

    the Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) measured

    depression and anxiety respectively, and schizotypal traits were measured using the schizotypal

    Personality Questionnaire (SPQ). Findings: It was found that ecstasy use was associated

    with depression, anxiety and schizotypal trait scores. There was no relationship between

    these measures and the level of ecstasy use. Conclusions: Ecstasy use per se was associated

    with self-report depression and anxiety, replicating previous literature. Furthermore,

    ecstasy users reported more schizotypal traits, something which had not been investigated

    in any previous research.

    Key words: ecstasy, MDMA,

Publication Date


  • 2010

Citation


  • Woods, L. & Barkus, E. (2010). Ecstasy (MDMA) and its relationship with self report depression, anxiety and schizotypy.. Clinica y Salud, 21 (2), 151-157.

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=1966&context=hbspapers

Ro Metadata Url


  • http://ro.uow.edu.au/hbspapers/917

Number Of Pages


  • 6

Start Page


  • 151

End Page


  • 157

Volume


  • 21

Issue


  • 2